Treatment of Epstein-Barr virus-induced posttransplantation lymphoproliferative disorder with Foscarnet alone in an adult after simultaneous heart and renal transplantation

Transplantation

Volumn 67, Issue 5, 1999, Pages 765-767

  Oertel, Stephan H K ^a   Ruhnke, Markus S ^a   Anagnostopoulos, Ioannis ^b   Kahl, Andreas A A H ^a   Frewer, Andreas F W ^a   Bechstein, Wolf O ^a   Hummel, Manfred W ^c   Riess, Hanno B ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; FOSCARNET; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; CASE REPORT; CONGESTIVE HEART FAILURE; EPSTEIN BARR VIRUS; FOLLOW UP; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REMISSION; VIRUS PATHOGENESIS;

EID: 0033559062     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199903150-00023     Document Type: Article

References (8)

1. Penn I. Cancers complicating organ transplantation. N Engl J Med. 1990; 323: 1767.
2. Frizzera G, Hanto DW, Gajl-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 1981; 41: 4253.
3. Starzl TE, Nalesnik MA, Porter KA, et al. reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1984; 1: 583.
4. Hanto DW, Frizzera G, Gajl-Peczalska KJ, et al. Epstein-Barr Virus induced B-cell lymphoma after renal transplantation. Acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med 1982; 306: 913.
5. Swinnen L, Mullen G, Fisher R, et al. Aggressive treatment for postcardiac transplant lymphoproliferation. Blood 1995; 9: 3333.
6. Öberg B. Antiviral effects of phosphonoformate. Pharmac Ther 1989; 2: 213.
7. Hanto DW, Frizzera G, Najarian JS, et al. Acyclovir therapy of Epstein-Barr virus-induced posttransplant lymphoproliferative disease. Trans Proc 1985; 1: 89.
8. Oertel St, Ruhnke M, Hummel M, et al. A standardized approach for treatment of post-transplantation lymphoproliferative disorders (PT-LPD) after solid organ transplantation - a proposal. Blood 1998; 10(suppl 1): 239b.